Trending News
NDA informs the public that its offices will be closed on Friday 20th April 2018 to enable staff attend an annual staff retreat. –
read more
Official Response NDA to a petition by Mark Kamanzi, the interdicted Head Legal Services –
read more
Drug Register of April 2018 now available –
read more
Search
Image Gallery
GMP Compliant Facilities
Upcoming Events
Contact us
Regional offices
Tenders / Bids
Home
About NDA
Authority Members
Organogram
Office of the Secretary to the Authority
NDA Quality Policy
Guidelines
Human Medicine
Herbal Medicine
Veterinary Medicine
Medical Devices
Nutritional Supplements
FAQ
Frequently Asked Questions
Directorates
Directorate of Inspectorate Services
Directorate of Product Assessment & Registration
Directorate of Product Safety
Directorate of Corporate Services
Directorate of Laboratory Services
Licensed Outlets
Drug Register
Downloads
Downloads and Publications
Manuals
Product Safety
NDPA Act & Regulations
Reports
Drug Alerts & Product Recalls
Client Charter
Drug Assessment and Registration
Drug Information
Service Delivery Timelines
Tenders / Bids
Veterinary Drugs
Regions
Central Regional
South Eastern
Western Region
South Western Region
Eastern Region
Northern Region
Jobs
INTERNAL ADVERT
Jobs
Forms
Application forms
Veterinary medicines
Human medicines
Public Health Products
Human Herbal medicines
Drug Information
Clinical Trials
Application Forms
Drug Register
Downloads & Publications
General Guidelines
Internal Advert
News Highlights
Official Response of the National Drug Authority (NDA) to a petition by Mark Kamanzi, the interdicted Head Legal Services, National Drug Authority on alleged illegalities and irregularities at the Authority
April 16th 2018
Public Notice
April 11th 2018
NDA secures court conviction
April 6th 2018
Risk of Drug interactions and side effects due to using Herbal remedies alongside anticancer treatment
March 29th 2018
To all pharmaceutical importers, distributors and retailers : Notice to cease purchase and use of Rabicid-iv (Rabeprazole Injection ip)
March 23rd 2018
Notice to all Market Authorization Holders & Local Technical Representatives
March 22nd 2018
The National Drug Quality control laboratory of NDA extends its ISO/IEC 17025 accreditation to Glove testing.
March 5th 2018
Risk of hypersensitivity reaction in infants and children following administration ff Nevirapine
February 15th 2018
South Western Region Office- Mbarara
House 29 Mbaguta Estates, Kamukuzi
P.O Box 1886 Mbarara, Uganda
Tel: (+256) 485 421 088
Fax: (+256) 485 421 220
